The microbiota in gastrointestinal pathophysiology :: implications for human health, prebiotics, probiotics, and dysbiosis /
The Microbiota in Gastrointestinal Pathophysiology: Implications for Human Health, Prebiotics, Probiotics and Dysbiosis is a one-stop reference on the state-of-the-art research on gut microbial ecology in relation to human disease. This important resource starts with an overview of the normal microb...
Gespeichert in:
| Weitere Verfasser: | , , |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Amsterdam :
Elsevier,
[2017]
|
| Schlagworte: | |
| Online-Zugang: | Volltext Volltext |
| Zusammenfassung: | The Microbiota in Gastrointestinal Pathophysiology: Implications for Human Health, Prebiotics, Probiotics and Dysbiosis is a one-stop reference on the state-of-the-art research on gut microbial ecology in relation to human disease. This important resource starts with an overview of the normal microbiota of the gastrointestinal tract, including the esophagus, stomach, Ileum, and colon. The book then identifies what a healthy vs. unhealthy microbial community looks like, including methods of identification. Also included is insight into which features and contributions the microbiota make that are essential and useful to host physiology, as is information on how to promote appropriate mutualisms and prevent undesirable dysbioses. Through the power of synthesizing what is known by experienced researchers in the field, current gaps are closed, raising understanding of the role of the microbiome and allowing for further research. |
| Beschreibung: | 1 online resource |
| Bibliographie: | Includes bibliographical references and index. |
| ISBN: | 9780128040621 0128040629 |
Internformat
MARC
| LEADER | 00000cam a2200000 i 4500 | ||
|---|---|---|---|
| 001 | ZDB-4-EBA-ocn964359929 | ||
| 003 | OCoLC | ||
| 005 | 20241004212047.0 | ||
| 006 | m o d | ||
| 007 | cr cnu---unuuu | ||
| 008 | 161122t20172017ne ob 001 0 eng d | ||
| 040 | |a IDEBK |b eng |e rda |e pn |c IDEBK |d N$T |d EBLCP |d N$T |d YDX |d OPELS |d OCLCF |d MERUC |d UPM |d OCLCQ |d IDEBK |d OCLCO |d OTZ |d OCLCO |d MERER |d OCLCQ |d CHVBK |d OCLCO |d D6H |d UAB |d OCLCO |d U3W |d OCLCO |d OCLCQ |d DKU |d OCLCO |d CASUM |d OCLCO |d GZM |d WYU |d OCLCO |d OCLCA |d LVT |d OCLCQ |d ESU |d OCLCA |d OCLCQ |d S2H |d OCLCO |d VT2 |d SFB |d OCLCO |d OCLCQ |d OCL |d OCLCO |d OCLCL | ||
| 016 | 7 | |a 101701304 |2 DNLM | |
| 019 | |a 963932041 |a 964336049 |a 1004972866 |a 1066448213 |a 1073060193 |a 1235840712 |a 1294676956 | ||
| 020 | |a 9780128040621 |q (electronic bk.) | ||
| 020 | |a 0128040629 |q (electronic bk.) | ||
| 020 | |z 9780128040249 | ||
| 020 | |z 0128040246 | ||
| 035 | |a (OCoLC)964359929 |z (OCoLC)963932041 |z (OCoLC)964336049 |z (OCoLC)1004972866 |z (OCoLC)1066448213 |z (OCoLC)1073060193 |z (OCoLC)1235840712 |z (OCoLC)1294676956 | ||
| 050 | 4 | |a RC801 | |
| 060 | 4 | |a 2017 B-527 | |
| 060 | 4 | |a WI 140 | |
| 072 | 7 | |a HEA |x 039000 |2 bisacsh | |
| 072 | 7 | |a MED |x 014000 |2 bisacsh | |
| 072 | 7 | |a MED |x 022000 |2 bisacsh | |
| 072 | 7 | |a MED |x 112000 |2 bisacsh | |
| 072 | 7 | |a MED |x 045000 |2 bisacsh | |
| 082 | 7 | |a 616.33 |2 23 | |
| 049 | |a MAIN | ||
| 245 | 0 | 4 | |a The microbiota in gastrointestinal pathophysiology : |b implications for human health, prebiotics, probiotics, and dysbiosis / |c edited by Martin H. Floch, Yehuda Ringel, W. Allan Walker. |
| 264 | 1 | |a Amsterdam : |b Elsevier, |c [2017] | |
| 264 | 4 | |c ©2017 | |
| 300 | |a 1 online resource | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 588 | 0 | |a Online resource; title from PDF title page (EBSCO, viewed December 22, 2016). | |
| 504 | |a Includes bibliographical references and index. | ||
| 505 | 0 | |a Part A. The Microbiota of the Gastrointestinal Tract -- 1. The Upper Gastrointestinal Tract -- Esophagus and Stomach -- 2. Characterizing and Functionally Defining the Gut Microbiota: Methodology and Implications -- 3. Microbiota of the Gastrointestinal Tract in Infancy -- 4. Identification of the Microbiota in the Aging Process -- Part B. Common Organisms and Probiotics -- 5. Escherichia coli Nissle 1917 -- 6. Probiotics of the Acidophilus Group: Lactobacillus acidophilus, delbrueckii subsp. bulgaricus and johnsonii -- 7. Lactobacillus rhamnosus GG -- 8. Lactobacillus reuteri -- 9. The Use of Lactobacillus casei and Lactobacillus paracasei in Clinical Trials for the Improvement of Human Health -- 10. Beneficial Influences of Lactobacillus plantarum on Human Health and Disease -- 11. Use of Bacillus in Human Intestinal Probiotic Applications | |
| 505 | 8 | |a 12. Bifidobacteria as Probiotic Organisms: An Introduction -- 13. Bifidobacterium animalis spp. lactis -- 14. Bifidobacterium bifidum -- 15. Bifidobacterium breve -- 16. Bifidobacterium longum -- 17. Bifidobacterium longum spp. infantis -- 18. Common Organisms and Probiotics: Saccharomyces boulardii -- 19. Common Organisms and Probiotics: Streptococcus thermophilus (Streptococcus salivarius subsp. thermophilus) -- 20. Complexities and Pitfalls in the Production of Multispecies Probiotics: The Paradigmatic Case of VSL#3 Formulation and Visbiome -- 21. The Viruses of the Gut Microbiota -- Part C. Food Substrates Important to the Microbiota -- 22. Dietary Fiber, Soluble and Insoluble, Carbohydrates, Fructose, and Lipids -- 23. Prebiotics: Inulin and Other Oligosaccharides -- 24. The Benefits of Yogurt, Cultures, and Fermentation -- Part D. Basic Physiologic Effects of Microbiota -- 25. Dysbiosis | |
| 505 | 8 | |a 26. Immunologic Response in the Host -- 27. Gastrointestinal Microbiota and the Neural System -- 28. Effect on the Host Metabolism -- 29. Relationship Between Gut Microbiota, Energy Metabolism, and Obesity -- 30. Taxonomic and Metagenomic Alterations of Microbiota in Bariatric Surgery -- 31. The Influence of Microbiota on Mechanisms of Bariatric Surgery -- Part E. Management of Disease and Disorders by Prebiotics and Probiotic Therapy -- 32. Allergic and Immunologic Disorders -- 33. Probiotics Use in Infectious Disease (Respiratory, Diarrhea, and Antibiotic-Associated Diarrhea) -- 34. FMT in Clostridium difficile and Other Potential Uses -- 35. Probiotics in the Treatment of Pouchitis -- 36. Probiotic Treatment in Crohn's Disease -- 37. Treatment of Inflammatory Bowel Disease in Ulcerative Colitis -- 38. Treatment of Functional Bowel Disorders With Prebiotics and Probiotics -- 39. Celiac Disease, the Microbiome, and Probiotics -- 40. Probiotics for the Treatment of Liver Disease | |
| 505 | 8 | |a 41. The Prevention and Treatment of Radiation and Chemotherapy-Induced Intestinal Mucositis -- 42. The Role of the Brain -- Gut -- Microbiome in Mental Health and Mental Disorders -- 43. Management of Disease and Disorders by Prebiotics and Probiotic Therapy: Probiotics in Bacterial Vaginosis. | |
| 520 | |a The Microbiota in Gastrointestinal Pathophysiology: Implications for Human Health, Prebiotics, Probiotics and Dysbiosis is a one-stop reference on the state-of-the-art research on gut microbial ecology in relation to human disease. This important resource starts with an overview of the normal microbiota of the gastrointestinal tract, including the esophagus, stomach, Ileum, and colon. The book then identifies what a healthy vs. unhealthy microbial community looks like, including methods of identification. Also included is insight into which features and contributions the microbiota make that are essential and useful to host physiology, as is information on how to promote appropriate mutualisms and prevent undesirable dysbioses. Through the power of synthesizing what is known by experienced researchers in the field, current gaps are closed, raising understanding of the role of the microbiome and allowing for further research. | ||
| 650 | 0 | |a Gastrointestinal system |x Diseases. |0 http://id.loc.gov/authorities/subjects/sh85053488 | |
| 650 | 0 | |a Microbiotheria. |0 http://id.loc.gov/authorities/subjects/sh99010655 | |
| 650 | 0 | |a Dietary supplements. |0 http://id.loc.gov/authorities/subjects/sh85037861 | |
| 650 | 0 | |a Intestines |x Microbiology. |0 http://id.loc.gov/authorities/subjects/sh85067595 | |
| 650 | 0 | |a Human beings. |0 http://id.loc.gov/authorities/subjects/sh85080292 | |
| 650 | 0 | 2 | |a Humans |
| 650 | 1 | 2 | |a Gastrointestinal Diseases |
| 650 | 2 | 2 | |a Dietary Supplements |
| 650 | 2 | 2 | |a Dysbiosis |
| 650 | 2 | 2 | |a Gastrointestinal Microbiome |
| 650 | 6 | |a Tractus gastro-intestinal |x Maladies. | |
| 650 | 6 | |a Microbiothères. | |
| 650 | 6 | |a Compléments alimentaires. | |
| 650 | 6 | |a Dysbiose. | |
| 650 | 6 | |a Intestins |x Microbiologie. | |
| 650 | 6 | |a Êtres humains. | |
| 650 | 7 | |a Microbiotheria (order) |2 aat | |
| 650 | 7 | |a Homo sapiens (species) |2 aat | |
| 650 | 7 | |a HEALTH & FITNESS |x Diseases |x General. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Clinical Medicine. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Diseases. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Evidence-Based Medicine. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Internal Medicine. |2 bisacsh | |
| 650 | 7 | |a Intestines |x Microbiology |2 fast | |
| 650 | 7 | |a Dietary supplements |2 fast | |
| 650 | 7 | |a Gastrointestinal system |x Diseases |2 fast | |
| 650 | 7 | |a Microbiotheria |2 fast | |
| 655 | 0 | |a Electronic books. | |
| 655 | 4 | |a Internet Resources. | |
| 700 | 1 | |a Floch, Martin H., |e editor. |0 http://id.loc.gov/authorities/names/n80094422 | |
| 700 | 1 | |a Ringel, Yehuda, |e editor. | |
| 700 | 1 | |a Walker, W. Allen, |e editor. | |
| 758 | |i has work: |a The microbiota in gastrointestinal pathophysiology (Text) |1 https://id.oclc.org/worldcat/entity/E39PCFv6xgFbdX9BYpRpRC3fbd |4 https://id.oclc.org/worldcat/ontology/hasWork | ||
| 776 | 0 | 8 | |i Print version: |t Microbiota in gastrointestinal pathophysiology. |d Amsterdam : Elsevier, [2017] |z 0128040246 |z 9780128040249 |w (OCoLC)958448883 |
| 856 | 4 | 0 | |l FWS01 |p ZDB-4-EBA |q FWS_PDA_EBA |u https://www.sciencedirect.com/science/book/9780128040249 |3 Volltext |
| 856 | 4 | 0 | |l FWS01 |p ZDB-4-EBA |q FWS_PDA_EBA |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1158585 |3 Volltext |
| 938 | |a ProQuest Ebook Central |b EBLB |n EBL4745403 | ||
| 938 | |a EBSCOhost |b EBSC |n 1158585 | ||
| 938 | |a ProQuest MyiLibrary Digital eBook Collection |b IDEB |n cis36984652 | ||
| 938 | |a YBP Library Services |b YANK |n 13271541 | ||
| 994 | |a 92 |b GEBAY | ||
| 912 | |a ZDB-4-EBA | ||
| 049 | |a DE-863 | ||
Datensatz im Suchindex
| DE-BY-FWS_katkey | ZDB-4-EBA-ocn964359929 |
|---|---|
| _version_ | 1816882370425389056 |
| adam_text | |
| any_adam_object | |
| author2 | Floch, Martin H. Ringel, Yehuda Walker, W. Allen |
| author2_role | edt edt edt |
| author2_variant | m h f mh mhf y r yr w a w wa waw |
| author_GND | http://id.loc.gov/authorities/names/n80094422 |
| author_facet | Floch, Martin H. Ringel, Yehuda Walker, W. Allen |
| building | Verbundindex |
| bvnumber | localFWS |
| callnumber-first | R - Medicine |
| callnumber-label | RC801 |
| callnumber-raw | RC801 |
| callnumber-search | RC801 |
| callnumber-sort | RC 3801 |
| callnumber-subject | RC - Internal Medicine |
| collection | ZDB-4-EBA |
| contents | Part A. The Microbiota of the Gastrointestinal Tract -- 1. The Upper Gastrointestinal Tract -- Esophagus and Stomach -- 2. Characterizing and Functionally Defining the Gut Microbiota: Methodology and Implications -- 3. Microbiota of the Gastrointestinal Tract in Infancy -- 4. Identification of the Microbiota in the Aging Process -- Part B. Common Organisms and Probiotics -- 5. Escherichia coli Nissle 1917 -- 6. Probiotics of the Acidophilus Group: Lactobacillus acidophilus, delbrueckii subsp. bulgaricus and johnsonii -- 7. Lactobacillus rhamnosus GG -- 8. Lactobacillus reuteri -- 9. The Use of Lactobacillus casei and Lactobacillus paracasei in Clinical Trials for the Improvement of Human Health -- 10. Beneficial Influences of Lactobacillus plantarum on Human Health and Disease -- 11. Use of Bacillus in Human Intestinal Probiotic Applications 12. Bifidobacteria as Probiotic Organisms: An Introduction -- 13. Bifidobacterium animalis spp. lactis -- 14. Bifidobacterium bifidum -- 15. Bifidobacterium breve -- 16. Bifidobacterium longum -- 17. Bifidobacterium longum spp. infantis -- 18. Common Organisms and Probiotics: Saccharomyces boulardii -- 19. Common Organisms and Probiotics: Streptococcus thermophilus (Streptococcus salivarius subsp. thermophilus) -- 20. Complexities and Pitfalls in the Production of Multispecies Probiotics: The Paradigmatic Case of VSL#3 Formulation and Visbiome -- 21. The Viruses of the Gut Microbiota -- Part C. Food Substrates Important to the Microbiota -- 22. Dietary Fiber, Soluble and Insoluble, Carbohydrates, Fructose, and Lipids -- 23. Prebiotics: Inulin and Other Oligosaccharides -- 24. The Benefits of Yogurt, Cultures, and Fermentation -- Part D. Basic Physiologic Effects of Microbiota -- 25. Dysbiosis 26. Immunologic Response in the Host -- 27. Gastrointestinal Microbiota and the Neural System -- 28. Effect on the Host Metabolism -- 29. Relationship Between Gut Microbiota, Energy Metabolism, and Obesity -- 30. Taxonomic and Metagenomic Alterations of Microbiota in Bariatric Surgery -- 31. The Influence of Microbiota on Mechanisms of Bariatric Surgery -- Part E. Management of Disease and Disorders by Prebiotics and Probiotic Therapy -- 32. Allergic and Immunologic Disorders -- 33. Probiotics Use in Infectious Disease (Respiratory, Diarrhea, and Antibiotic-Associated Diarrhea) -- 34. FMT in Clostridium difficile and Other Potential Uses -- 35. Probiotics in the Treatment of Pouchitis -- 36. Probiotic Treatment in Crohn's Disease -- 37. Treatment of Inflammatory Bowel Disease in Ulcerative Colitis -- 38. Treatment of Functional Bowel Disorders With Prebiotics and Probiotics -- 39. Celiac Disease, the Microbiome, and Probiotics -- 40. Probiotics for the Treatment of Liver Disease 41. The Prevention and Treatment of Radiation and Chemotherapy-Induced Intestinal Mucositis -- 42. The Role of the Brain -- Gut -- Microbiome in Mental Health and Mental Disorders -- 43. Management of Disease and Disorders by Prebiotics and Probiotic Therapy: Probiotics in Bacterial Vaginosis. |
| ctrlnum | (OCoLC)964359929 |
| dewey-full | 616.33 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.33 |
| dewey-search | 616.33 |
| dewey-sort | 3616.33 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>08350cam a2200973 i 4500</leader><controlfield tag="001">ZDB-4-EBA-ocn964359929</controlfield><controlfield tag="003">OCoLC</controlfield><controlfield tag="005">20241004212047.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr cnu---unuuu</controlfield><controlfield tag="008">161122t20172017ne ob 001 0 eng d</controlfield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">IDEBK</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="e">pn</subfield><subfield code="c">IDEBK</subfield><subfield code="d">N$T</subfield><subfield code="d">EBLCP</subfield><subfield code="d">N$T</subfield><subfield code="d">YDX</subfield><subfield code="d">OPELS</subfield><subfield code="d">OCLCF</subfield><subfield code="d">MERUC</subfield><subfield code="d">UPM</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">IDEBK</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OTZ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">MERER</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">CHVBK</subfield><subfield code="d">OCLCO</subfield><subfield code="d">D6H</subfield><subfield code="d">UAB</subfield><subfield code="d">OCLCO</subfield><subfield code="d">U3W</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">DKU</subfield><subfield code="d">OCLCO</subfield><subfield code="d">CASUM</subfield><subfield code="d">OCLCO</subfield><subfield code="d">GZM</subfield><subfield code="d">WYU</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCA</subfield><subfield code="d">LVT</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">ESU</subfield><subfield code="d">OCLCA</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">S2H</subfield><subfield code="d">OCLCO</subfield><subfield code="d">VT2</subfield><subfield code="d">SFB</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCL</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCL</subfield></datafield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">101701304</subfield><subfield code="2">DNLM</subfield></datafield><datafield tag="019" ind1=" " ind2=" "><subfield code="a">963932041</subfield><subfield code="a">964336049</subfield><subfield code="a">1004972866</subfield><subfield code="a">1066448213</subfield><subfield code="a">1073060193</subfield><subfield code="a">1235840712</subfield><subfield code="a">1294676956</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780128040621</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0128040629</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">9780128040249</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">0128040246</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)964359929</subfield><subfield code="z">(OCoLC)963932041</subfield><subfield code="z">(OCoLC)964336049</subfield><subfield code="z">(OCoLC)1004972866</subfield><subfield code="z">(OCoLC)1066448213</subfield><subfield code="z">(OCoLC)1073060193</subfield><subfield code="z">(OCoLC)1235840712</subfield><subfield code="z">(OCoLC)1294676956</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RC801</subfield></datafield><datafield tag="060" ind1=" " ind2="4"><subfield code="a">2017 B-527</subfield></datafield><datafield tag="060" ind1=" " ind2="4"><subfield code="a">WI 140</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">HEA</subfield><subfield code="x">039000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MED</subfield><subfield code="x">014000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MED</subfield><subfield code="x">022000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MED</subfield><subfield code="x">112000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MED</subfield><subfield code="x">045000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="082" ind1="7" ind2=" "><subfield code="a">616.33</subfield><subfield code="2">23</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">MAIN</subfield></datafield><datafield tag="245" ind1="0" ind2="4"><subfield code="a">The microbiota in gastrointestinal pathophysiology :</subfield><subfield code="b">implications for human health, prebiotics, probiotics, and dysbiosis /</subfield><subfield code="c">edited by Martin H. Floch, Yehuda Ringel, W. Allan Walker.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Amsterdam :</subfield><subfield code="b">Elsevier,</subfield><subfield code="c">[2017]</subfield></datafield><datafield tag="264" ind1=" " ind2="4"><subfield code="c">©2017</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="588" ind1="0" ind2=" "><subfield code="a">Online resource; title from PDF title page (EBSCO, viewed December 22, 2016).</subfield></datafield><datafield tag="504" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index.</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">Part A. The Microbiota of the Gastrointestinal Tract -- 1. The Upper Gastrointestinal Tract -- Esophagus and Stomach -- 2. Characterizing and Functionally Defining the Gut Microbiota: Methodology and Implications -- 3. Microbiota of the Gastrointestinal Tract in Infancy -- 4. Identification of the Microbiota in the Aging Process -- Part B. Common Organisms and Probiotics -- 5. Escherichia coli Nissle 1917 -- 6. Probiotics of the Acidophilus Group: Lactobacillus acidophilus, delbrueckii subsp. bulgaricus and johnsonii -- 7. Lactobacillus rhamnosus GG -- 8. Lactobacillus reuteri -- 9. The Use of Lactobacillus casei and Lactobacillus paracasei in Clinical Trials for the Improvement of Human Health -- 10. Beneficial Influences of Lactobacillus plantarum on Human Health and Disease -- 11. Use of Bacillus in Human Intestinal Probiotic Applications</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">12. Bifidobacteria as Probiotic Organisms: An Introduction -- 13. Bifidobacterium animalis spp. lactis -- 14. Bifidobacterium bifidum -- 15. Bifidobacterium breve -- 16. Bifidobacterium longum -- 17. Bifidobacterium longum spp. infantis -- 18. Common Organisms and Probiotics: Saccharomyces boulardii -- 19. Common Organisms and Probiotics: Streptococcus thermophilus (Streptococcus salivarius subsp. thermophilus) -- 20. Complexities and Pitfalls in the Production of Multispecies Probiotics: The Paradigmatic Case of VSL#3 Formulation and Visbiome -- 21. The Viruses of the Gut Microbiota -- Part C. Food Substrates Important to the Microbiota -- 22. Dietary Fiber, Soluble and Insoluble, Carbohydrates, Fructose, and Lipids -- 23. Prebiotics: Inulin and Other Oligosaccharides -- 24. The Benefits of Yogurt, Cultures, and Fermentation -- Part D. Basic Physiologic Effects of Microbiota -- 25. Dysbiosis</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">26. Immunologic Response in the Host -- 27. Gastrointestinal Microbiota and the Neural System -- 28. Effect on the Host Metabolism -- 29. Relationship Between Gut Microbiota, Energy Metabolism, and Obesity -- 30. Taxonomic and Metagenomic Alterations of Microbiota in Bariatric Surgery -- 31. The Influence of Microbiota on Mechanisms of Bariatric Surgery -- Part E. Management of Disease and Disorders by Prebiotics and Probiotic Therapy -- 32. Allergic and Immunologic Disorders -- 33. Probiotics Use in Infectious Disease (Respiratory, Diarrhea, and Antibiotic-Associated Diarrhea) -- 34. FMT in Clostridium difficile and Other Potential Uses -- 35. Probiotics in the Treatment of Pouchitis -- 36. Probiotic Treatment in Crohn's Disease -- 37. Treatment of Inflammatory Bowel Disease in Ulcerative Colitis -- 38. Treatment of Functional Bowel Disorders With Prebiotics and Probiotics -- 39. Celiac Disease, the Microbiome, and Probiotics -- 40. Probiotics for the Treatment of Liver Disease</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">41. The Prevention and Treatment of Radiation and Chemotherapy-Induced Intestinal Mucositis -- 42. The Role of the Brain -- Gut -- Microbiome in Mental Health and Mental Disorders -- 43. Management of Disease and Disorders by Prebiotics and Probiotic Therapy: Probiotics in Bacterial Vaginosis.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The Microbiota in Gastrointestinal Pathophysiology: Implications for Human Health, Prebiotics, Probiotics and Dysbiosis is a one-stop reference on the state-of-the-art research on gut microbial ecology in relation to human disease. This important resource starts with an overview of the normal microbiota of the gastrointestinal tract, including the esophagus, stomach, Ileum, and colon. The book then identifies what a healthy vs. unhealthy microbial community looks like, including methods of identification. Also included is insight into which features and contributions the microbiota make that are essential and useful to host physiology, as is information on how to promote appropriate mutualisms and prevent undesirable dysbioses. Through the power of synthesizing what is known by experienced researchers in the field, current gaps are closed, raising understanding of the role of the microbiome and allowing for further research.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Gastrointestinal system</subfield><subfield code="x">Diseases.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85053488</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Microbiotheria.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh99010655</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Dietary supplements.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85037861</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Intestines</subfield><subfield code="x">Microbiology.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85067595</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Human beings.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85080292</subfield></datafield><datafield tag="650" ind1="0" ind2="2"><subfield code="a">Humans</subfield></datafield><datafield tag="650" ind1="1" ind2="2"><subfield code="a">Gastrointestinal Diseases</subfield></datafield><datafield tag="650" ind1="2" ind2="2"><subfield code="a">Dietary Supplements</subfield></datafield><datafield tag="650" ind1="2" ind2="2"><subfield code="a">Dysbiosis</subfield></datafield><datafield tag="650" ind1="2" ind2="2"><subfield code="a">Gastrointestinal Microbiome</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Tractus gastro-intestinal</subfield><subfield code="x">Maladies.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Microbiothères.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Compléments alimentaires.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Dysbiose.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Intestins</subfield><subfield code="x">Microbiologie.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Êtres humains.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Microbiotheria (order)</subfield><subfield code="2">aat</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Homo sapiens (species)</subfield><subfield code="2">aat</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HEALTH & FITNESS</subfield><subfield code="x">Diseases</subfield><subfield code="x">General.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL</subfield><subfield code="x">Clinical Medicine.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL</subfield><subfield code="x">Diseases.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL</subfield><subfield code="x">Evidence-Based Medicine.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL</subfield><subfield code="x">Internal Medicine.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Intestines</subfield><subfield code="x">Microbiology</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Dietary supplements</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Gastrointestinal system</subfield><subfield code="x">Diseases</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Microbiotheria</subfield><subfield code="2">fast</subfield></datafield><datafield tag="655" ind1=" " ind2="0"><subfield code="a">Electronic books.</subfield></datafield><datafield tag="655" ind1=" " ind2="4"><subfield code="a">Internet Resources.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Floch, Martin H.,</subfield><subfield code="e">editor.</subfield><subfield code="0">http://id.loc.gov/authorities/names/n80094422</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ringel, Yehuda,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Walker, W. Allen,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="758" ind1=" " ind2=" "><subfield code="i">has work:</subfield><subfield code="a">The microbiota in gastrointestinal pathophysiology (Text)</subfield><subfield code="1">https://id.oclc.org/worldcat/entity/E39PCFv6xgFbdX9BYpRpRC3fbd</subfield><subfield code="4">https://id.oclc.org/worldcat/ontology/hasWork</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Print version:</subfield><subfield code="t">Microbiota in gastrointestinal pathophysiology.</subfield><subfield code="d">Amsterdam : Elsevier, [2017]</subfield><subfield code="z">0128040246</subfield><subfield code="z">9780128040249</subfield><subfield code="w">(OCoLC)958448883</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="l">FWS01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FWS_PDA_EBA</subfield><subfield code="u">https://www.sciencedirect.com/science/book/9780128040249</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="l">FWS01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FWS_PDA_EBA</subfield><subfield code="u">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1158585</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">ProQuest Ebook Central</subfield><subfield code="b">EBLB</subfield><subfield code="n">EBL4745403</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">EBSCOhost</subfield><subfield code="b">EBSC</subfield><subfield code="n">1158585</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">ProQuest MyiLibrary Digital eBook Collection</subfield><subfield code="b">IDEB</subfield><subfield code="n">cis36984652</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">YBP Library Services</subfield><subfield code="b">YANK</subfield><subfield code="n">13271541</subfield></datafield><datafield tag="994" ind1=" " ind2=" "><subfield code="a">92</subfield><subfield code="b">GEBAY</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-863</subfield></datafield></record></collection> |
| genre | Electronic books. Internet Resources. |
| genre_facet | Electronic books. Internet Resources. |
| id | ZDB-4-EBA-ocn964359929 |
| illustrated | Not Illustrated |
| indexdate | 2024-11-27T13:27:32Z |
| institution | BVB |
| isbn | 9780128040621 0128040629 |
| language | English |
| oclc_num | 964359929 |
| open_access_boolean | |
| owner | MAIN DE-863 DE-BY-FWS |
| owner_facet | MAIN DE-863 DE-BY-FWS |
| physical | 1 online resource |
| psigel | ZDB-4-EBA |
| publishDate | 2017 |
| publishDateSearch | 2017 |
| publishDateSort | 2017 |
| publisher | Elsevier, |
| record_format | marc |
| spelling | The microbiota in gastrointestinal pathophysiology : implications for human health, prebiotics, probiotics, and dysbiosis / edited by Martin H. Floch, Yehuda Ringel, W. Allan Walker. Amsterdam : Elsevier, [2017] ©2017 1 online resource text txt rdacontent computer c rdamedia online resource cr rdacarrier Online resource; title from PDF title page (EBSCO, viewed December 22, 2016). Includes bibliographical references and index. Part A. The Microbiota of the Gastrointestinal Tract -- 1. The Upper Gastrointestinal Tract -- Esophagus and Stomach -- 2. Characterizing and Functionally Defining the Gut Microbiota: Methodology and Implications -- 3. Microbiota of the Gastrointestinal Tract in Infancy -- 4. Identification of the Microbiota in the Aging Process -- Part B. Common Organisms and Probiotics -- 5. Escherichia coli Nissle 1917 -- 6. Probiotics of the Acidophilus Group: Lactobacillus acidophilus, delbrueckii subsp. bulgaricus and johnsonii -- 7. Lactobacillus rhamnosus GG -- 8. Lactobacillus reuteri -- 9. The Use of Lactobacillus casei and Lactobacillus paracasei in Clinical Trials for the Improvement of Human Health -- 10. Beneficial Influences of Lactobacillus plantarum on Human Health and Disease -- 11. Use of Bacillus in Human Intestinal Probiotic Applications 12. Bifidobacteria as Probiotic Organisms: An Introduction -- 13. Bifidobacterium animalis spp. lactis -- 14. Bifidobacterium bifidum -- 15. Bifidobacterium breve -- 16. Bifidobacterium longum -- 17. Bifidobacterium longum spp. infantis -- 18. Common Organisms and Probiotics: Saccharomyces boulardii -- 19. Common Organisms and Probiotics: Streptococcus thermophilus (Streptococcus salivarius subsp. thermophilus) -- 20. Complexities and Pitfalls in the Production of Multispecies Probiotics: The Paradigmatic Case of VSL#3 Formulation and Visbiome -- 21. The Viruses of the Gut Microbiota -- Part C. Food Substrates Important to the Microbiota -- 22. Dietary Fiber, Soluble and Insoluble, Carbohydrates, Fructose, and Lipids -- 23. Prebiotics: Inulin and Other Oligosaccharides -- 24. The Benefits of Yogurt, Cultures, and Fermentation -- Part D. Basic Physiologic Effects of Microbiota -- 25. Dysbiosis 26. Immunologic Response in the Host -- 27. Gastrointestinal Microbiota and the Neural System -- 28. Effect on the Host Metabolism -- 29. Relationship Between Gut Microbiota, Energy Metabolism, and Obesity -- 30. Taxonomic and Metagenomic Alterations of Microbiota in Bariatric Surgery -- 31. The Influence of Microbiota on Mechanisms of Bariatric Surgery -- Part E. Management of Disease and Disorders by Prebiotics and Probiotic Therapy -- 32. Allergic and Immunologic Disorders -- 33. Probiotics Use in Infectious Disease (Respiratory, Diarrhea, and Antibiotic-Associated Diarrhea) -- 34. FMT in Clostridium difficile and Other Potential Uses -- 35. Probiotics in the Treatment of Pouchitis -- 36. Probiotic Treatment in Crohn's Disease -- 37. Treatment of Inflammatory Bowel Disease in Ulcerative Colitis -- 38. Treatment of Functional Bowel Disorders With Prebiotics and Probiotics -- 39. Celiac Disease, the Microbiome, and Probiotics -- 40. Probiotics for the Treatment of Liver Disease 41. The Prevention and Treatment of Radiation and Chemotherapy-Induced Intestinal Mucositis -- 42. The Role of the Brain -- Gut -- Microbiome in Mental Health and Mental Disorders -- 43. Management of Disease and Disorders by Prebiotics and Probiotic Therapy: Probiotics in Bacterial Vaginosis. The Microbiota in Gastrointestinal Pathophysiology: Implications for Human Health, Prebiotics, Probiotics and Dysbiosis is a one-stop reference on the state-of-the-art research on gut microbial ecology in relation to human disease. This important resource starts with an overview of the normal microbiota of the gastrointestinal tract, including the esophagus, stomach, Ileum, and colon. The book then identifies what a healthy vs. unhealthy microbial community looks like, including methods of identification. Also included is insight into which features and contributions the microbiota make that are essential and useful to host physiology, as is information on how to promote appropriate mutualisms and prevent undesirable dysbioses. Through the power of synthesizing what is known by experienced researchers in the field, current gaps are closed, raising understanding of the role of the microbiome and allowing for further research. Gastrointestinal system Diseases. http://id.loc.gov/authorities/subjects/sh85053488 Microbiotheria. http://id.loc.gov/authorities/subjects/sh99010655 Dietary supplements. http://id.loc.gov/authorities/subjects/sh85037861 Intestines Microbiology. http://id.loc.gov/authorities/subjects/sh85067595 Human beings. http://id.loc.gov/authorities/subjects/sh85080292 Humans Gastrointestinal Diseases Dietary Supplements Dysbiosis Gastrointestinal Microbiome Tractus gastro-intestinal Maladies. Microbiothères. Compléments alimentaires. Dysbiose. Intestins Microbiologie. Êtres humains. Microbiotheria (order) aat Homo sapiens (species) aat HEALTH & FITNESS Diseases General. bisacsh MEDICAL Clinical Medicine. bisacsh MEDICAL Diseases. bisacsh MEDICAL Evidence-Based Medicine. bisacsh MEDICAL Internal Medicine. bisacsh Intestines Microbiology fast Dietary supplements fast Gastrointestinal system Diseases fast Microbiotheria fast Electronic books. Internet Resources. Floch, Martin H., editor. http://id.loc.gov/authorities/names/n80094422 Ringel, Yehuda, editor. Walker, W. Allen, editor. has work: The microbiota in gastrointestinal pathophysiology (Text) https://id.oclc.org/worldcat/entity/E39PCFv6xgFbdX9BYpRpRC3fbd https://id.oclc.org/worldcat/ontology/hasWork Print version: Microbiota in gastrointestinal pathophysiology. Amsterdam : Elsevier, [2017] 0128040246 9780128040249 (OCoLC)958448883 FWS01 ZDB-4-EBA FWS_PDA_EBA https://www.sciencedirect.com/science/book/9780128040249 Volltext FWS01 ZDB-4-EBA FWS_PDA_EBA https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1158585 Volltext |
| spellingShingle | The microbiota in gastrointestinal pathophysiology : implications for human health, prebiotics, probiotics, and dysbiosis / Part A. The Microbiota of the Gastrointestinal Tract -- 1. The Upper Gastrointestinal Tract -- Esophagus and Stomach -- 2. Characterizing and Functionally Defining the Gut Microbiota: Methodology and Implications -- 3. Microbiota of the Gastrointestinal Tract in Infancy -- 4. Identification of the Microbiota in the Aging Process -- Part B. Common Organisms and Probiotics -- 5. Escherichia coli Nissle 1917 -- 6. Probiotics of the Acidophilus Group: Lactobacillus acidophilus, delbrueckii subsp. bulgaricus and johnsonii -- 7. Lactobacillus rhamnosus GG -- 8. Lactobacillus reuteri -- 9. The Use of Lactobacillus casei and Lactobacillus paracasei in Clinical Trials for the Improvement of Human Health -- 10. Beneficial Influences of Lactobacillus plantarum on Human Health and Disease -- 11. Use of Bacillus in Human Intestinal Probiotic Applications 12. Bifidobacteria as Probiotic Organisms: An Introduction -- 13. Bifidobacterium animalis spp. lactis -- 14. Bifidobacterium bifidum -- 15. Bifidobacterium breve -- 16. Bifidobacterium longum -- 17. Bifidobacterium longum spp. infantis -- 18. Common Organisms and Probiotics: Saccharomyces boulardii -- 19. Common Organisms and Probiotics: Streptococcus thermophilus (Streptococcus salivarius subsp. thermophilus) -- 20. Complexities and Pitfalls in the Production of Multispecies Probiotics: The Paradigmatic Case of VSL#3 Formulation and Visbiome -- 21. The Viruses of the Gut Microbiota -- Part C. Food Substrates Important to the Microbiota -- 22. Dietary Fiber, Soluble and Insoluble, Carbohydrates, Fructose, and Lipids -- 23. Prebiotics: Inulin and Other Oligosaccharides -- 24. The Benefits of Yogurt, Cultures, and Fermentation -- Part D. Basic Physiologic Effects of Microbiota -- 25. Dysbiosis 26. Immunologic Response in the Host -- 27. Gastrointestinal Microbiota and the Neural System -- 28. Effect on the Host Metabolism -- 29. Relationship Between Gut Microbiota, Energy Metabolism, and Obesity -- 30. Taxonomic and Metagenomic Alterations of Microbiota in Bariatric Surgery -- 31. The Influence of Microbiota on Mechanisms of Bariatric Surgery -- Part E. Management of Disease and Disorders by Prebiotics and Probiotic Therapy -- 32. Allergic and Immunologic Disorders -- 33. Probiotics Use in Infectious Disease (Respiratory, Diarrhea, and Antibiotic-Associated Diarrhea) -- 34. FMT in Clostridium difficile and Other Potential Uses -- 35. Probiotics in the Treatment of Pouchitis -- 36. Probiotic Treatment in Crohn's Disease -- 37. Treatment of Inflammatory Bowel Disease in Ulcerative Colitis -- 38. Treatment of Functional Bowel Disorders With Prebiotics and Probiotics -- 39. Celiac Disease, the Microbiome, and Probiotics -- 40. Probiotics for the Treatment of Liver Disease 41. The Prevention and Treatment of Radiation and Chemotherapy-Induced Intestinal Mucositis -- 42. The Role of the Brain -- Gut -- Microbiome in Mental Health and Mental Disorders -- 43. Management of Disease and Disorders by Prebiotics and Probiotic Therapy: Probiotics in Bacterial Vaginosis. Gastrointestinal system Diseases. http://id.loc.gov/authorities/subjects/sh85053488 Microbiotheria. http://id.loc.gov/authorities/subjects/sh99010655 Dietary supplements. http://id.loc.gov/authorities/subjects/sh85037861 Intestines Microbiology. http://id.loc.gov/authorities/subjects/sh85067595 Human beings. http://id.loc.gov/authorities/subjects/sh85080292 Humans Gastrointestinal Diseases Dietary Supplements Dysbiosis Gastrointestinal Microbiome Tractus gastro-intestinal Maladies. Microbiothères. Compléments alimentaires. Dysbiose. Intestins Microbiologie. Êtres humains. Microbiotheria (order) aat Homo sapiens (species) aat HEALTH & FITNESS Diseases General. bisacsh MEDICAL Clinical Medicine. bisacsh MEDICAL Diseases. bisacsh MEDICAL Evidence-Based Medicine. bisacsh MEDICAL Internal Medicine. bisacsh Intestines Microbiology fast Dietary supplements fast Gastrointestinal system Diseases fast Microbiotheria fast |
| subject_GND | http://id.loc.gov/authorities/subjects/sh85053488 http://id.loc.gov/authorities/subjects/sh99010655 http://id.loc.gov/authorities/subjects/sh85037861 http://id.loc.gov/authorities/subjects/sh85067595 http://id.loc.gov/authorities/subjects/sh85080292 |
| title | The microbiota in gastrointestinal pathophysiology : implications for human health, prebiotics, probiotics, and dysbiosis / |
| title_auth | The microbiota in gastrointestinal pathophysiology : implications for human health, prebiotics, probiotics, and dysbiosis / |
| title_exact_search | The microbiota in gastrointestinal pathophysiology : implications for human health, prebiotics, probiotics, and dysbiosis / |
| title_full | The microbiota in gastrointestinal pathophysiology : implications for human health, prebiotics, probiotics, and dysbiosis / edited by Martin H. Floch, Yehuda Ringel, W. Allan Walker. |
| title_fullStr | The microbiota in gastrointestinal pathophysiology : implications for human health, prebiotics, probiotics, and dysbiosis / edited by Martin H. Floch, Yehuda Ringel, W. Allan Walker. |
| title_full_unstemmed | The microbiota in gastrointestinal pathophysiology : implications for human health, prebiotics, probiotics, and dysbiosis / edited by Martin H. Floch, Yehuda Ringel, W. Allan Walker. |
| title_short | The microbiota in gastrointestinal pathophysiology : |
| title_sort | microbiota in gastrointestinal pathophysiology implications for human health prebiotics probiotics and dysbiosis |
| title_sub | implications for human health, prebiotics, probiotics, and dysbiosis / |
| topic | Gastrointestinal system Diseases. http://id.loc.gov/authorities/subjects/sh85053488 Microbiotheria. http://id.loc.gov/authorities/subjects/sh99010655 Dietary supplements. http://id.loc.gov/authorities/subjects/sh85037861 Intestines Microbiology. http://id.loc.gov/authorities/subjects/sh85067595 Human beings. http://id.loc.gov/authorities/subjects/sh85080292 Humans Gastrointestinal Diseases Dietary Supplements Dysbiosis Gastrointestinal Microbiome Tractus gastro-intestinal Maladies. Microbiothères. Compléments alimentaires. Dysbiose. Intestins Microbiologie. Êtres humains. Microbiotheria (order) aat Homo sapiens (species) aat HEALTH & FITNESS Diseases General. bisacsh MEDICAL Clinical Medicine. bisacsh MEDICAL Diseases. bisacsh MEDICAL Evidence-Based Medicine. bisacsh MEDICAL Internal Medicine. bisacsh Intestines Microbiology fast Dietary supplements fast Gastrointestinal system Diseases fast Microbiotheria fast |
| topic_facet | Gastrointestinal system Diseases. Microbiotheria. Dietary supplements. Intestines Microbiology. Human beings. Humans Gastrointestinal Diseases Dietary Supplements Dysbiosis Gastrointestinal Microbiome Tractus gastro-intestinal Maladies. Microbiothères. Compléments alimentaires. Dysbiose. Intestins Microbiologie. Êtres humains. Microbiotheria (order) Homo sapiens (species) HEALTH & FITNESS Diseases General. MEDICAL Clinical Medicine. MEDICAL Diseases. MEDICAL Evidence-Based Medicine. MEDICAL Internal Medicine. Intestines Microbiology Dietary supplements Gastrointestinal system Diseases Microbiotheria Electronic books. Internet Resources. |
| url | https://www.sciencedirect.com/science/book/9780128040249 https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1158585 |
| work_keys_str_mv | AT flochmartinh themicrobiotaingastrointestinalpathophysiologyimplicationsforhumanhealthprebioticsprobioticsanddysbiosis AT ringelyehuda themicrobiotaingastrointestinalpathophysiologyimplicationsforhumanhealthprebioticsprobioticsanddysbiosis AT walkerwallen themicrobiotaingastrointestinalpathophysiologyimplicationsforhumanhealthprebioticsprobioticsanddysbiosis AT flochmartinh microbiotaingastrointestinalpathophysiologyimplicationsforhumanhealthprebioticsprobioticsanddysbiosis AT ringelyehuda microbiotaingastrointestinalpathophysiologyimplicationsforhumanhealthprebioticsprobioticsanddysbiosis AT walkerwallen microbiotaingastrointestinalpathophysiologyimplicationsforhumanhealthprebioticsprobioticsanddysbiosis |